🇺🇸 FDA
Pipeline program

KB301

PEARL-1

Phase 1 mab active

Quick answer

KB301 for Skin Roughness is a Phase 1 program (mab) at Krystal Biotech Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Krystal Biotech Netherlands B.V.
Indication
Skin Roughness
Phase
Phase 1
Modality
mab
Status
active

Clinical trials